Recently, researchers from the Yale School of Medicine published their evaluation of the efficacy of the Alcat Test for food sensitivity for management of patients with IBS. (, et al Efficacy of individualized diets in patients with irritable bowel syndrome: a randomized controlled trial. .
They reported on symptom outcome, proteomic evaluation on strong responders, and corollary inflammatory pathways. Taken together this data sheds light on the pathomechanisms of cellular reactions to foods and use of a non-drug approach toward the management of a condition that afflicts approximately 15 – 20% of the US population.
Please join us for a very exciting webinar on the research findings by Wajahat Mehal, PhD, MD, Head of the Digestive Disease Section at Yale School of Medicine, at, New Haven, CT , and followed by live questions and answers.
Dr. Wajahat Mehal is a gastroenterologist and the lead Professor of Medicine (Digestive Diseases) at the Yale School of Medicine and the Director of the Yale Weight Loss Program, obtained his MD and PhD (Immunology) from Oxford University Medical School, having completed his certification for AB of Internal Medicine for Gastroenterology in 2001. Dr. Mehal is involved in many departments and organizations including, Internal Medicine: Digestive Diseases; Hepatology: Viral Hepatitis Program; Metabolic Health and Weight Loss Program; Liver Center and more. He has performed extensive research into Sterile Inflammation, Liver Fibrosis, and Liver Immunology. His research is cited in almost a dozen publications.